Marshall Wace’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.71M | Sell |
60,223
-394,972
| -87% | -$11.2M | ﹤0.01% | 1521 |
|
|
2025
Q1 | $13.4M | Buy |
455,195
+292,332
| +179% | +$8.63M | 0.02% | 607 |
|
|
2024
Q4 | $4.74M | Sell |
162,863
-19,342
| -11% | -$562K | 0.01% | 1004 |
|
|
2024
Q3 | $8.37M | Buy |
182,205
+70,435
| +63% | +$3.24M | 0.01% | 754 |
|
|
2024
Q2 | $4.57M | Buy |
111,770
+9,906
| +10% | +$405K | 0.01% | 936 |
|
|
2024
Q1 | $2.6M | Sell |
101,864
-95,852
| -48% | -$2.45M | ﹤0.01% | 1093 |
|
|
2023
Q4 | $1.79M | Buy |
+197,716
| New | +$1.79M | ﹤0.01% | 1049 |
|
|
2022
Q3 | – | Sell |
-264,588
| Closed | -$3.85M | – | 2993 |
|
|
2022
Q2 | $3.85M | Hold |
264,588
| – | – | 0.01% | 1320 |
|
|
2022
Q1 | $4.89M | Hold |
264,588
| – | – | 0.01% | 1238 |
|
|
2021
Q4 | $6.29M | Buy |
264,588
+249,755
| +1,684% | +$5.94M | 0.01% | 1078 |
|
|
2021
Q3 | $365K | Hold |
14,833
| – | – | ﹤0.01% | 1995 |
|
|
2021
Q2 | $367K | Buy |
+14,833
| New | +$367K | ﹤0.01% | 1773 |
|